A detailed history of Qrg Capital Management, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 2,177 shares of CRL stock, worth $332,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,177
Previous 1,557 39.82%
Holding current value
$332,536
Previous $234 Million 40.94%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

BUY
$99.75 - $151.89 $61,845 - $94,171
620 Added 39.82%
2,177 $330 Million
Q1 2025

Apr 17, 2025

BUY
$150.52 - $190.14 $26,341 - $33,274
175 Added 12.66%
1,557 $234 Million
Q4 2024

Feb 05, 2025

BUY
$178.58 - $220.69 $246,797 - $304,993
1,382 New
1,382 $255 Million
Q1 2024

May 07, 2024

BUY
$203.52 - $273.43 $213,085 - $286,281
1,047 New
1,047 $284 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.77B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Qrg Capital Management, Inc. Portfolio

Follow Qrg Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qrg Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Qrg Capital Management, Inc. with notifications on news.